
Stefan Vaaks
2024 CBB Stats
PTS
0.0
REB
0.0
AST
0.0
STL
0.0
BLK
0.0
ROS Projections
Good to go Wednesday
Vaaks (illness) is available to play in Wednesday's game against Marquette, Bill Koch of The Providence Journal reports.
ANALYSIS
Vaaks will be available to play after a two-game absence due to an illness. The freshman guard totaled 54 points, 10 rebounds and seven assists across his last three outings prior to the injury.
Vaaks will be available to play after a two-game absence due to an illness. The freshman guard totaled 54 points, 10 rebounds and seven assists across his last three outings prior to the injury.
College Basketball Stats
Loading CBB Stats...
2025
2025 CBB Game Log
Loading Game Log...
2024 CBB Split Stats
Loading CBB Stats...
Friars Depth Chart
Our full team depth charts are reserved for RotoWire subscribers.
Subscribe Now
Recent RotoWire Articles Featuring Stefan Vaaks See More
More Fantasy News
Questionable against Marquette
Vaaks (illness) is questionable for Wednesday's game against Marquette.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.
Dealing with flu
Vaaks (illness) was held out of Saturday's game against Creighton due to the flu, per Tom Harkness of Big East Vault.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.
Out vs. Creighton
Vaaks (undisclosed) is listed out ahead of Saturday's game against Creighton.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.
DNP Wednesday
Vaaks (illness) was held out of Wednesday's 94-84 win over Xavier due to illness, Bill Koch of The Providence Journal reports.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.
Lands on injury report
Vaaks (undisclosed) is questionable for Wednesday's game against Xavier.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.
